Individualized risk in newly diagnosed multiple myeloma

被引:0
|
作者
Maura, Francesco [1 ]
Rajanna, Arjun [1 ]
Ziccheddu, Bachisio [1 ]
Derkach, Andriy [2 ]
Poos, Alexandra [3 ,4 ]
Maclachlan, Kylee [5 ]
Boyle, Eileen [6 ]
Hultcrantz, Malin [5 ]
Silva, Ariosto [7 ]
Jackson, Graham [8 ]
Kaiser, Martin [9 ]
Pawlyn, Charlotte [9 ]
Cook, Gordon [10 ]
Bergsagel, Leif [11 ]
Goldschmidt, Hartmut [12 ]
Weisel, Katja [13 ]
Fenk, Roland [14 ]
Mai, Elias [2 ,15 ]
Raab, Marc [16 ]
van Rhee, Frits [17 ]
Usmani, Saad [2 ]
Shain, Ken [7 ]
Weinhold, Niels [3 ,4 ]
Morgan, Gareth [18 ]
Landgren, Ola [19 ]
机构
[1] Univ Miami, Coral Gables, FL 33124 USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Heidelberg Univ Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany
[4] German Canc Res Ctr, Clin Cooperat Unit Mol Hematol Oncol, Heidelberg, Germany
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA
[6] UCL Canc Inst, Myeloma Res, London, England
[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[8] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[9] Inst Canc Res, London, England
[10] Univ Leeds, Leeds, W Yorkshire, England
[11] Mayo Clin Arizona, Phoenix, AZ USA
[12] Univ Hosp Heidelberg, GMMG Study Grp, Internal Med 5, Heidelberg, Germany
[13] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[14] Univ Hosp Heidelberg, Hematol & Blood & Marrow Transplant, Heidelberg, Germany
[15] Univ Hosp Heidelberg, GMMG Study Grp, Heidelberg, Germany
[16] Univ Hosp Heidelberg, Heidelberg, Germany
[17] Univ Arkansas Med Sci, Myeloma Ctr, Little Rock, AR 72205 USA
[18] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA
[19] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Serv, Coral Gables, FL 33124 USA
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-357
引用
收藏
页码:S236 / S236
页数:1
相关论文
共 50 条
  • [41] Radiomics-Based Biomarkers for Risk Stratification in Newly Diagnosed Multiple Myeloma
    Shreve, Jacob T.
    Howe, Michael D.
    Guzman, Emmanuel Contreras
    Charalampous, Charalampos
    Gonsalves, Wilson I.
    Buadi, Francis
    Kourelis, Taxiarchis
    Hayman, Suzanne R.
    Gertz, Morie A.
    Fonseca, Rafael
    Rajkumar, S. Vincent
    Dasari, Surendra
    Thorpe, Matthew P.
    Broski, Stephen
    Kumar, Shaji
    Binder, Moritz
    BLOOD, 2024, 144 : 4711 - 4712
  • [42] Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma
    Geng, Chuanying
    Yang, Guangzhong
    Zhou, Huixing
    Wang, Huijuan
    Li, Yanchen
    Leng, Yun
    Zhang, Zhiyao
    Jian, Yuan
    Chen, Wenming
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):
  • [43] Management of newly diagnosed transplant ineligible multiple myeloma
    Atrash, Shebli
    Bhutani, Manisha
    Paul, Barry
    Voorhees, Peter M.
    Usmani, Saad Z.
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2549 - 2560
  • [44] Treatment paradigms for the newly diagnosed patient with multiple myeloma
    Greipp, P
    SEMINARS IN HEMATOLOGY, 2005, 42 (04) : S16 - S21
  • [45] Molecular profiling of newly diagnosed multiple myeloma.
    Zhan, FH
    Hardin, J
    Bumm, K
    Zheng, MZ
    Tian, EM
    Crowley, J
    Tricot, G
    Barlogie, B
    Shaughnessy, J
    BLOOD, 2001, 98 (11) : 733A - 733A
  • [46] Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
    Palumbo, Antonio
    Hajek, Roman
    Delforge, Michel
    Kropff, Martin
    Petrucci, Maria Teresa
    Catalano, John
    Gisslinger, Heinz
    Wiktor-Jedrzejczak, Wieslaw
    Zodelava, Mamia
    Weisel, Katja
    Cascavilla, Nicola
    Iosava, Genadi
    Cavo, Michele
    Kloczko, Janusz
    Blade, Joan
    Beksac, Meral
    Spicka, Ivan
    Plesner, Torben
    Radke, Joergen
    Langer, Christian
    Ben Yehuda, Dina
    Corso, Alessandro
    Herbein, Lindsay
    Yu, Zhinuan
    Mei, Jay
    Jacques, Christian
    Dimopoulos, Meletios A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19): : 1759 - 1769
  • [47] Nonmyeloablative allografting or autografting for newly diagnosed multiple myeloma
    Bruno, B.
    Rotta, M.
    Patriarca, F.
    Mordini, N.
    Allione, B.
    Carnevale-Schianca, F.
    Giaccone, L.
    Sorasio, R.
    Omede, P.
    Baldi, I.
    Bringhen, S.
    Massaia, M.
    Aglietta, M.
    Levis, A.
    Gallamini, A.
    Fanin, R.
    Palumbo, A.
    Storb, R.
    Ciccone, G.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 41 - 41
  • [48] Evolution of Treatment Paradigms in Newly Diagnosed Multiple Myeloma
    Elnair, Radowan A.
    Holstein, Sarah A.
    DRUGS, 2021, 81 (07) : 825 - 840
  • [49] TREATMENT OF NEWLY DIAGNOSED MULTIPLE MYELOMA: GOALS AND OPTIONS
    Tacchetti, P.
    Zamagni, E.
    Pantani, L.
    Cavo, M.
    HAEMATOLOGICA, 2017, 102 : 212 - 215
  • [50] Treatment patterns and outcomes in newly diagnosed multiple myeloma
    Shah, Jash Yogesh
    Nair, Aditya Ranjithkumar
    Mishra, Dhyey Rajkumar
    Bagal, Bhausaheb
    Jain, Hasmukh
    Nayak, Lingaraj
    Tembhare, Prashant
    Saha, Saswata
    Gokarn, Anant
    Punatar, Sachin
    Shetty, Dhanlaxmi
    Mirgh, Sumeet
    Shetty, Alok
    Jindal, Nishant
    Patil, Vasundhara
    Sengar, Manju
    Khattry, Navin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S125 - S125